Hi Dr. Coomer —
You've helped build one of the largest dental benefits operations in the country. This isn't a list of what Humana is doing wrong. It's an outside-in look at where your carrier's preventive-benefit posture is visible, where it's silent, and where the next competitive move lives.
This is a strategic observation, not a product proposal. Paul is happy to discuss either — but the audit itself stops at the opportunity line.
Humana at a glance
| Entity | Humana Inc. (NYSE: HUM) |
| Headquartered | Louisville, KY |
| Dental operation | HumanaDental, CompBenefits, DentiCare |
| Dental members | ~13M (MA, Medicaid, Group, Individual) |
| Product lines | Preventive Value, Preventive Plus, Humana Extend |
| Research arm | research.humana.com |
| Notable program | HumanaChoice Diabetes and Heart (C-SNP) |
Preventive Maturity Score Needs Work
A composite across seven dimensions. Reflects public posture.
What Humana is already doing well
Preventive in product naming
Humana is rare: "Preventive" is actually the name of a tier (Preventive Value). That's a strong commitment signal compared to burying it in generic PPO names.
100% coverage mechanics
Group dental includes enhanced preventive care — up to 3 routine cleanings/year. Coverage mechanics are clean with no waiting periods.
Research infrastructure
An established, peer-reviewed clinical research arm (research.humana.com) that pure-play dental carriers simply cannot match in scale or trust.
The Three Gaps
The Oral-Systemic Silence
The Data: You operate HumanaChoice Diabetes/Heart C-SNP. Aetna’s DMI program saves $621K/employer doing exactly this. Humana has no public equivalent program.
The C-SNP population drives medical claims escalation, yet the oral-systemic angle is completely silent.
What closing this looks like
- Named initiative tied to C-SNP
- Funded preventive device benefit
- Research output from research.humana.com
Preventive-Device Blind Spot
The Data: Zero mentions of home-care devices across all public plans. The FEDVIP brochure explicitly excludes them. 33% of members skip preventive benefits entirely.
The non-utilizing cohort is costing you real money in downstream restorative claims.
What closing this looks like
- A carrier-branded home-care device benefit
- Opt-in for commercial, embedded for C-SNP
- Measure YoY restorative claims
The Narrative Vacuum
The Data: Public content is framed entirely on access/affordability (e.g. "$18/mo"), skipping the ROI story entirely. MetLife, Delta, Aetna all have flagship outcome publications.
Consultants have no Humana-authored outcome data to reference in RFPs.
What closing this looks like
- "The 33% Problem" whitepaper
- Co-authored with clinical advisory board
- Anchored in pilot data
AI Search Visibility What employers see in LLMs
Competitive Snapshot
| Dimension | Humana | Aetna | MetLife | Delta | Cigna |
|---|---|---|---|---|---|
| Preventive in product naming | ✓ Yes | — | — | — | ✓ Yes |
| Flagship oral-systemic program | Missing | DMI | SpotLite | State of Oral Health | OHIP |
| Public preventive-device benefit | Missing | Missing | Missing | Missing | Missing |
| Clinical evidence research arm | ✓ Unused for oral-med | — | — | — | — |
| Chronic-disease dental integration | C-SNP footprint (unnamed) | DMI | SpotLite | — | OHIP |
The Opportunity An untaken category
Three observations from this audit converge on one possibility:
- 33% of Humana members never activate their preventive benefit in a given year.
- No major dental carrier currently offers a preventive-device benefit as part of its coverage.
- The AI-search layer shows an uncontested lane: zero carriers own the queries where employers and members ask about home-care tool coverage.
What this suggests is a new benefit category — positioned between pure preventive coverage and full clinical care — that extends the preventive benefit to the home. It reaches the non-utilizing cohort without asking them to overcome the barriers that kept them out of the chair. It is a claims-reduction lever, a member-satisfaction lever, and a competitive differentiator — in that order.
The economics that follow are sized to this category — not to any specific program, vendor, or product configuration.
Illustrative Economics 30% Adoption Pilot
A device-based preventive benefit can be structured to compete with the second annual cleaning for the same budget dollar — the non-utilizing member never used that cleaning, but the budget was already earmarked.
Built from public industry benchmarks, assuming 13M dental members × 30% pilot adoption = 3.9M enrolled.
- Unit Economics: +$96 / member (retained cleaning rev - device cost)
- Restorative Reduction: Conservative 5% YoY
- Trade-a-cleaning savings: ~$374M
- Restorative reduction savings: ~$59M
Even at 1/10th adoption, the program self-funds by Year 2 on device economics alone.
90-Day Roadmap
Let's compare notes in Scottsdale
This audit is personalized to Humana based on 29 years of insurance-channel work. If any of this is useful, I'd value 15 minutes of your time at the AADC 2026 show.